PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 78 filers reported holding PLIANT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,471,885 | +3.8% | 200,224 | +8.4% | 0.00% | 0.0% |
Q2 2023 | $3,345,785 | +395.4% | 184,646 | +627.3% | 0.00% | – |
Q1 2023 | $675,321 | +138.0% | 25,388 | +73.0% | 0.00% | – |
Q4 2022 | $283,707 | -61.3% | 14,677 | -58.2% | 0.00% | – |
Q3 2022 | $733,000 | +762.4% | 35,114 | +232.2% | 0.00% | – |
Q2 2022 | $85,000 | -83.4% | 10,570 | -85.6% | 0.00% | – |
Q1 2022 | $513,000 | -48.3% | 73,299 | -0.2% | 0.00% | – |
Q4 2021 | $992,000 | -21.1% | 73,462 | -1.4% | 0.00% | – |
Q3 2021 | $1,257,000 | -27.2% | 74,470 | +25.6% | 0.00% | – |
Q2 2021 | $1,727,000 | -75.0% | 59,290 | -66.3% | 0.00% | -100.0% |
Q1 2021 | $6,920,000 | +222.5% | 175,948 | +86.3% | 0.00% | – |
Q4 2020 | $2,146,000 | +9.9% | 94,451 | +9.6% | 0.00% | – |
Q3 2020 | $1,953,000 | +198.6% | 86,190 | +327.9% | 0.00% | – |
Q2 2020 | $654,000 | – | 20,142 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |